Current stock page

Financial Data

CI Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - Healthcare PlansScore data as of Sep 4, 2026

CI

Financial Data
Cigna Corporation
Healthcare· Medical - Healthcare Plans
AIQ Score
NeutralAIQ Edge 7/10
Low Priority
Above Peers
Score data as of Sep 4, 2026
Last price
$282.52
-$3.74 (-1.31%)
Latest market quote
Momentum60
Value72
Quality39
Risk Resilience52
Sentiment
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 5, 2026.

Income statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Revenue$71.67B$68.49B$72.47B$69.75B$67.23B$65.5B$65.65B$63.69B
Gross Profit$14.97B$6.47B$5.55B$5.94B$7.89B$6.61B$6.46B$6.6B
Operating Income
Net Income$1.66B$1.65B$1.23B$1.87B$1.53B$1.32B$1.42B$739M
EPS$6.29$6.3$4.64$7.02$5.76$4.88$5.13$2.65
Cash flow statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Operating Cash Flow-$421M$1.13B$6.15B$3.42B-$1.89B$1.92B$5.21B$46M
Capital Expenditure-$297M-$267M-$322M-$278M-$285M-$327M-$337M-$399M
Free Cash Flow-$718M$864M$5.83B$3.14B-$2.17B$1.59B$4.88B-$353M
Net Cash Provided By Operating Activities-$421M$1.13B$6.15B$3.42B-$1.89B$1.92B$5.21B$46M
Balance sheet
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Assets$157.08B$153.27B$157.92B$157.92B$151.65B$150.66B$155.88B$157.64B
Total Debt$32.09B$31.07B$0$34.21B$30.93B$30.59B$32.14B$32.96B
Cash And Cash Equivalents
Total Liabilities$114.17B$110.82B$116.05B$115.91B$111.22B$110.24B$114.64B$115.34B
Total Stockholders Equity$42.91B$42.44B$41.87B$42.01B$40.43B$40.41B$41.24B$42.3B
Key financial metrics
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio10.9610.5914.8310.2714.3617.4313.4732.63
P/B ratio1.711.6601.842.192.291.872.29
P/S ratio1.021.021.011.11.311.411.171.54
Debt To Equity0.750.7300.810.770.760.780.78
Free Cash Flow Yield
Financial ratios
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio
P/B ratio1.711.6601.842.192.291.872.29
P/S ratio1.021.021.011.11.311.411.171.54
Return On Equity3.89%3.92%0.00%4.47%3.81%3.29%3.47%1.76%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
11.67
multipleSep 4, 2026
Pb
1.75
multipleSep 4, 2026
Revenue Growth Yoy
4.63
percentSep 4, 2026
EPS Growth Yoy
-0.16
percentSep 4, 2026
Gross Margin
11.66
percentSep 4, 2026
Operating Margin
3.46
percentSep 4, 2026
ROE
15.24
percentSep 4, 2026
ROIC
7.69
percentSep 4, 2026
Debt To Equity
0.75
ratioSep 4, 2026
FCF Yield
12.18
percentSep 4, 2026
Technical indicators
Close
282.52
priceSep 4, 2026
Volume
1,204,767
volumeSep 4, 2026
Rsi14
59.57
indexSep 4, 2026
MACD
-0.02
indexSep 4, 2026
MACD Signal
-1.04
indexSep 4, 2026
MACD Histogram
1.02
indexSep 4, 2026
Adx14
9.65
indexSep 4, 2026
Sma50
283.45
priceSep 4, 2026
Sma200
279.58
priceSep 4, 2026
Atr14
6.28
priceSep 4, 2026
Historical Volatility
0.21
percentSep 4, 2026
Volume Ma20
1,394,043.8
volumeSep 4, 2026
Risk measures
Resilience Score
52
score_0_100Sep 4, 2026
Beta
0.32
ratioSep 4, 2026
Volatility Annual
32.52
percentSep 4, 2026
Max Drawdown
-21.41
percentSep 4, 2026
Sharpe Ratio
-0.18
ratioSep 4, 2026
Var95
-2.61
percentSep 4, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

CI Financial Data FAQ

What is Cigna Corporation's revenue?

Cigna Corporation's revenue is one of the core financial data points for CI. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Cigna Corporation's revenue growing?

Revenue growth shows whether Cigna Corporation is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is CI's EPS?

CI's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Cigna Corporation's net income?

Cigna Corporation's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Cigna Corporation generate?

Free cash flow shows how much cash Cigna Corporation generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Cigna Corporation have?

Cash and debt help frame CI's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.